Starpharma Holdings Limited
SPHRF
$0.084
$0.00020.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -46.16% | 14.90% | 48.99% | 49.37% | 49.08% |
| Total Depreciation and Amortization | -6.29% | -6.98% | -8.97% | -8.03% | -6.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.19% | -14.87% | -26.82% | -67.83% | -77.69% |
| Change in Net Operating Assets | 25.07% | 25.07% | 25.07% | -58.96% | -1,121.35% |
| Cash from Operations | -49.82% | 17.48% | 52.27% | 35.19% | -1.68% |
| Capital Expenditure | 34.58% | 74.77% | 85.98% | 85.80% | 85.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -25.00% | 378.57% |
| Cash from Investing | 30.35% | 74.07% | 85.73% | 86.25% | 86.41% |
| Total Debt Issued | -14.56% | -14.56% | -14.56% | -27.08% | -35.19% |
| Total Debt Repaid | 73.25% | -6.88% | -490.46% | -571.58% | -675.88% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 85.91% | -17.04% | -5,461.76% | -996.20% | -584.92% |
| Foreign Exchange rate Adjustments | -117.15% | -112.12% | -106.95% | -28.73% | 222.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.08% | 12.53% | 21.79% | -5.18% | -62.63% |